The Ivermectin Market encompasses three primary application segments: Human, Veterinary, and Agriculture. The human segment currently dominates the market, projected to grow from approximately $0.5 billion in 2024 to $1.5 billion by 2035, driven by sustained public health demand for neglected tropical disease (NTD) programs. The WHO's NTD road map targets elimination of...